Skip to content

Changes to visual acuity (clearness of vision) after Hyperbaric Oxygen Therapy

For patients receiving the standard protocol of Hyperbaric Oxygen Therapy (HBOT), does the delivery of oxygen via hood induce a greater extent of ocular refractive change in patients than in patients who received oxygen via mask?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000343707
Enrollment
120
Registered
2013-03-28
Start date
2013-03-19
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the study is to compare the extent of refractive change in patients receiving HBOT via hood vs mask. The results will aid in the understanding of the etiology of HBOT induced myopia, and aid in choosing the delivery method of HBOT in future treatment sessions. The investigators hypothesise greater refractive change in the hooded group, in keeping with results of previous studies.

Interventions

Patients are administered a minimum of 20 sessions of hyperbaric oxygen therapy (HBOT) in a multiplace chamber. Each session involves the delivery of 100% oxygen at 2.4ATA, for 90 minutes. Sessions will be administered once everyday consecutively (Mon-Fri), for a minimum of 20 sessions, up to 40 sessions (i.e. 20-40 working days) Patients in the intervention group will receive oxygen via a plastic hood that encloses the head. This creates a seal for oxygen to accumulate, allowing patients to br

Patients are administered a minimum of 20 sessions of hyperbaric oxygen therapy (HBOT) in a multiplace chamber. Each session involves the delivery of 100% oxygen at 2.4ATA, for 90 minutes. Sessions will be administered once everyday consecutively (Mon-Fri), for a minimum of 20 sessions, up to 40 sessions (i.e. 20-40 working days) Patients in the intervention group will receive oxygen via a plastic hood that encloses the head. This creates a seal for oxygen to accumulate, allowing patients to breathe in 100% oxygen.

Sponsors

Michael Bennett
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

HBOT indication of at least 20 sessions Minimal visual acuity of 6/12 or better Ability to receive HBOT via mask or hood

Exclusion criteria

Patient refusal to participate Patients using topical eye treatments

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026